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Abstract Myelinated axons are a beautiful example of
symbiotic interactions between two cell types: Myelinating
glial cells organize axonal membranes and build their
myelin sheaths to allow fast action potential conduction,
while axons regulate myelination and enhance the survival
of myelinating cells. Axonal demyelination, occurring in
neurodegenerative diseases or after a nerve injury, results in
severe motor and/or mental disabilities. Thus, understand-
ing how the myelination process is induced, regulated, and
maintained is crucial to develop new therapeutic strategies
for regeneration in the nervous system. Epigenetic regula-
tion has recently been recognized as a fundamental
contributing player. In this review, we focus on the central
mechanisms of gene regulation mediated by histone
deacetylation and other key functions of histone deacety-
lases in Schwann cells and oligodendrocytes, the myelinat-
ing glia of the peripheral and central nervous systems.
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Introduction
Myelin is found in the vertebrate nervous systems and in some
invertebrates, although its structure is different in invertebrates
[1–3]. This lipid-rich structure, conserved among species, is
necessary to avoid leakage of electric signals along axons
and to ensure saltatory impulse conduction [4]. The chemical
composition of myelin sheaths surrounding axons of the
peripheral nervous system (PNS) differs from that found in
the central nervous system (CNS) [5]. The reasons for these
differences are not fully understood, all the more so as
myelin in the PNS and CNS has apparently similar functions
[4]. One pragmatic explanation is that the two types of
myelin are produced by different cell types, Schwann cells in
the PNS and oligodendrocytes in the CNS, that have
different development origins. Although Schwann cells and
oligodendrocytes exert comparable supportive functions
towards axons, these two cell types differ in many ways. A
Schwann cell myelinates only a single internode of a single
axon, while an oligodendrocyte can myelinate up to 50
internodes [6, 7]. Even more striking are their different
regenerative properties: Schwann cells can efficiently pro-
mote axonal repair, whereas oligodendrocytes cannot. Thus,
only peripheral nerves can fully regenerate after an injury
[8]. This is largely due to the remarkable plasticity of
Schwann cells that can dedifferentiate and redifferentiate in
case of damage to foster axonal regrowth and restore
myelination. While the reasons for the differences between
myelinating glia in the PNS and CNS remain enigmatic,
differentiation and myelination processes of Schwann cells
and oligodendrocytes have been and are still extensively
studied. A large network of transcriptional activators and
repressors are known to control each differentiation step to
reach eventually the myelinating stage [7, 9–12]. Epigenetics
came only recently into place to show how this transcrip-
tional machinery is regulated by changes in chromatin
architecture. The involvement of epigenetics in the regula-
tion of the differentiation and myelination processes in
oligodendrocytes, and more recently in Schwann cells,
became now a very active area of investigation. We will
discuss this recent progress with a particular focus on histone
deacetylases (HDACs) and their epigenetic functions and
other crucial roles in myelinating glia.
Histone Deacetylases in Brief
The mammalian members of the HDAC family are, based on
their structures, subdivided into four main classes. Class I
(HDAC1, 2, 3, and 8), class II (HDAC4, 5, 6, 7, 9, and 10),
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and class IV (HDAC11), the “classical” HDACs, are
structurally related and need the presence of Zn2+ to be active
[13], whereas class III HDACs, the sirtuins (Sirt1–7), are a
group of enzymes dependent on NAD+ and structurally
unrelated to the classical HDACs [14]. Three members of
this group, Sirt4, Sirt6, and Sirt7, are commonly described as
part of the class III HDACs. However, these three sirtuins, as
well as the variant C of HDAC9 (also called HDPR), do not
exhibit deacetylase activity [15–18].
Most HDACs can remodel chromatin by the removal of
acetyl groups from histone tails [13, 14]. This favors
condensed chromatin architecture that limits DNA access for
transcription factors. Thus, HDACs control transcriptional
activity by their epigenetic functions, but also through non-
epigenetic regulation [19, 20]. Indeed, HDACs can deacety-
late a wide range of transcription factors, as well as other
proteins, and thereby modulate their activity. In addition to
their deacetylase activity, two members of the sirtuin group,
Sirt2 and Sirt3, can act also as mono-ADP-ribosyl transferases
[21, 22]. Two other sirtuins, Sirt4 and Sirt6, act only as mono-
ADP-ribosyl transferases [15, 16], and the enzymatic activity
of Sirt7 is not known [17].
Most HDACs can theoretically deacetylate histones and
remodel chromatin. However, their subcellular localization is
not always compatible with this function. HDAC3 and class II
HDACs shuttle from the nucleus to the cytoplasm, HDAC1
Fig. 1 HDACs control the differentiation and myelination processes
of Schwann cells (a) and oligodendrocytes (b). In a, the bold font
emphasizes the involvement of HDAC2 compared to HDAC1 in the
depicted mechanism. In b, the inset illustrates a potential role of alpha-
tubulin deacetylation mediated by HDAC6 and Sirt2, in the
differentiation process of oligodendrocytes. HDAC6 appears gray
since its expression in oligodendrocytes has not been proven in vivo.
The dashed arrow between PLP/DM20 and Sirt2 indicates that the
presence of Sirt2 in oligodendrocyte myelin is linked to PLP/DM20
expression by a yet unknown mechanism
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and Sirt1 are mostly nuclear but under certain circumstances
can be exported to the cytoplasm, HDAC6 and Sirt2 are
predominantly cytoplasmic, and Sirt3 and Sirt5 belong to the
mitochondrial compartment [13, 14]. In addition, Sirt4 is also
found in mitochondria and Sirt7 in the nucleolus [14]. To be
localized in the nucleus, HDACs need a nuclear localization
signal (NLS) or a binding partner that has an NLS [13].
Similarly, the HDACs possessing a nuclear export signal can
be exported to the cytoplasm [13, 23], usually by utilizing the
cellular export factor CRM1 [24, 25]. Even when nuclear,
HDACs do not bind to DNA directly and can deacetylate
histones only within complexes through interaction with
DNA-binding proteins. These protein complexes often
comprise two different HDACs: HDAC1 and HDAC2,
HDAC6 and HDAC11, HDAC3 and a class II HDAC,
HDAC10 and a class I or class II HDAC, a class I HDAC
and a sirtuin [13, 26]. What is the functional relevance of
recruiting two different HDACs into the same protein
complex? The activity of HDACs themselves can be
regulated by acetylation and deacetylation [27], opening the
possibility that one HDAC of the complex deacetylates
histones, while the other HDAC regulates the activity of the
first HDAC, or of another protein of the complex. Consistent
with this hypothesis, Sirt1 can be recruited to the mSin3A/
HDAC1 complex to modulate the histone deacetylase activity
of HDAC1 [26]. However, in most cases, the significance of
two HDACs in the same complex remains unknown.
Because histone deacetylation results in chromatin
compaction that limits DNA access for transcription factors,
HDACs are commonly seen as transcriptional corepressors
acting within complexes, such as NuRD, Sin3, CoREST,
NCoR/silencing mediator of retinoid and thyroid hormone
receptors (SMRT), the best characterized multiprotein
complexes containing class I HDACs [28]. However, recent
studies show that HDACs do not always silence gene
expression, but can instead participate also in transcriptional
activation [29–32]. Indeed, the study of Wang et al. [30]
shows that both histone acetyltransferases (HATs) and
HDACs are bound to transcriptionally active genes and
proposes that HDACs function to reset chromatin modifica-
tion states and to maintain an adequate level of acetylation to
keep genes active. In addition, low levels of HATs and
HDACs are found at the promoter of primed genes, where
HATs and HDACs act in concert to poise genes for further
activation [30].
HDACs in Control of Schwann Cell Differentiation
Schwann cells, the myelination-competent glia of the PNS,
need to undergo several steps of differentiation to reach the
myelinating stage. This journey starts with neural crest
cells, a stem cell population which also gives rise to other
cell types including sensory neurons, melanocytes, chon-
drocytes, and smooth muscle cells. After the specification
step into the glial cell lineage, Schwann cell precursors
differentiate into immature Schwann cells that surround
bundles of axons of different calibers. The next differentiation
step determines whether a Schwann cell will become
myelinating or non-myelinating. While small caliber axons
remain in bundles associated with non-myelinating Schwann
cells, large caliber axons are sorted into a one-to-one
relationship with Schwann cells. This process, called radial
sorting, leads to the pro-myelinating stage, where a Schwann
cell forms one-and-a-half wraps around an axon, but no
myelin yet. During the last differentiation step, Schwann cells
produce a thick myelin sheath around sorted axons (Schwann
cell development is reviewed in [9, 10]).
The process of Schwann cell differentiation is tightly
regulated by intracellular and extracellular cues, and only
when all necessary signals are perfectly orchestrated can
peripheral nerves become fully functional. Transcription
factors play a central role in this process [10]. Among the
many factors involved, Sox10, Oct6, and Krox20 are major
transcription factors controlling gene expression at early
and/or late stages of Schwann cell differentiation. Sox10 is
necessary for each differentiation step including the
specification from neural crest cells to the glial cell lineage
[33–37], Oct6 is important to induce the transition from the
pro-myelinating to the myelinating stage [38], and Krox20
is absolutely required for PNS myelination [39]. The
regulation of expression of these transcription factors is only
partially understood, but includes that Sox10 and Oct6 act
synergistically to induce Krox20 expression [40], while Oct6
expression depends on Sox10 and NF-kappaB [41, 42].
As for the regulation of Sox10 expression in Schwann
cells, little was known until two independent but related
studies identified HDAC1 and HDAC2 as positive regu-
lators of Sox10 expression. We [31] and Chen et al. [32]
deleted HDAC1 and HDAC2 in the Schwann cell lineage
by crossing mice expressing the Cre recombinase under the
control of Desert hedgehog regulatory sequences with mice
carrying floxed Hdac1 and floxed Hdac2 genes. Both
studies found that these two class I HDACs together are
absolutely required for Schwann cell myelination, with
HDAC1/2-double null Schwann cells being arrested at the
immature or the pro-myelinating stages. In addition, we
showed that concomitant depletion of HDAC1 and HDAC2
results in massive Schwann cell apoptosis, leading to
complete loss of Schwann cells 2 weeks after birth. We
also demonstrated that both HDACs interact with Sox10
upon induction of Schwann cell differentiation to bind to
the Sox10 promoter and the Krox20 MSE (myelinating
Schwann cell element). However, only HDAC2 acts in
synergy with Sox10 to activate the transcription of Sox10 and
Krox20, identifying HDAC2 as major regulator of the
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transcriptional program of myelination. Chen et al. [32]
discovered an additional mechanism regulating the Sox10
gene: HDAC1 and HDAC2 interact with and deacetylate
NF-kappaB, while the NF-kappaB/HDACs complex binds to
the Sox10 promoter and leads to an increase of the activating
histone mark H3K4me3 (trimethylated lysine 4 of histone
H3). In the absence of HDAC1 and HDAC2, NF-kappaB is
acetylated by P300/CBP resulting in an increase of the
repressing histone mark H3K9me3 on the Sox10 promoter.
Whether and how the two mechanisms are interconnected—
the one identified by us involving HDAC interaction with
Sox10 and the mechanism described by Chen et al.,
involving HDAC interaction with NF-kappaB—remains to
be elucidated.
We found also that HDAC1 limits the level of active
beta-catenin (ABC), the downstream effector of the Wnt
pathway, to maintain Schwann cell survival at the immature
and pro-myelinating stages [31]. ABC is kept at low steady-
state levels before myelination starts and increases when
myelination has started, negatively correlated with HDAC1
expression. Furthermore, Sox10 increases the levels of
ABC, and in turn, ABC increases expression of Sox10 and
Krox20. This suggests that ABC acts as an enhancer of the
myelination process after its induction, consistent with
recent results that identified Wnt/beta-catenin signaling as
driver of PNS myelin gene expression and myelination
[43]. However, ABC signaling can be efficiently adjusted,
possibly by activation of negative feedback loops, since
expression of constitutively active beta-catenin in mice does
not result in increased myelin thickness [32]. In contrast,
inactivation of beta-catenin in mice leads to delayed
myelination, further supporting a critical role of ABC in
the myelination process [44].
HDAC1 and HDAC2 also play a role in Krox20/Nab2-
mediated transcriptional repression of Id2 and Id4, two
inhibitors of myelination, and of Rad, a gene involved in
Rho signaling [45–47]. Rad inhibits Rho signaling, which
controls Schwann cell migration and the length of myelin-
ated segments [48, 49], and is downregulated during
myelination [50]. The Krox20/Nab2 complex may also
repress other genes, including Oct6 and myc [46]. Krox20
associates with Nab2 to repress the transcription of target
genes by the recruitment of the NuRD complex containing
HDAC1 and HDAC2 [45, 46]. This mechanism occurs
during the Schwann cell myelination process, and its
disruption leads to severe hypomyelination [51].
HDAC1, HDAC2, and HDAC3 have been implicated in
repression of the cyclin E gene through interaction with
Schwann cell factor 1 (SC1), a p75 neurotrophin receptor-
interacting protein and member of the PR/SET (positive
regulatory/suppressor of variegation, enhancer of zeste,
trithorax) domain-containing zinc finger protein family
[52]. Upon nerve growth factor induction, SC1 translocates
to the nucleus, binds to the cyclin E promoter, and recruits
HDAC1, HDAC2, and HDAC3 to repress cyclin E
transcription, resulting in cell proliferation arrest. These
studies have not been conducted in Schwann cells, but the
expression of SC1 and p75NTR in Schwann cells [53] is
consistent with the hypothesis that this mechanism may
mediate the obligatory cell cycle exit before induction of
Schwann cell myelination.
Besides class I HDACs, Sirt2, a member of the class III
HDACs, is likely to be involved in Schwann cell differen-
tiation. Sirt2 has been identified as a constitutive protein of
the myelin sheath, with enrichment in paranodal regions
[54].
In summary, the elucidation of functional roles of
HDACs in the differentiation and myelination program of
Schwann cells has recently made major steps forward. It is
clear now that these proteins play a key role in Schwann
cell biology. However, the studies are still at the beginning,
and more work is needed to fully unravel how histone
deacetylation and other central roles of HDACs orchestrate
the different steps of the Schwann cell differentiation process,
including the specification from neural crest cells into the glial
cell lineage. In addition, our current knowledge is restricted to
only a few members of the HDAC family, requiring further
studies to address the functions of other HDACs expressed in
Schwann cells.
Multitasking HDACs in Oligodendrocyte Differentiation
Oligodendrocytes, the myelination-competent glia of the
CNS, originate from neural stem cells (or neuroepithelial
precursor cells), which also give rise to neurons and
astrocytes. As with Schwann cells, oligodendrocytes need
to go through several steps of differentiation before
producing myelin. The first step consists in the specification
from neural stem cells into oligodendrocyte progenitor cells
(OPCs). OPCs then progress to differentiate into late
progenitors, also called pro-oligodendrocytes or oligoden-
droblasts. A fraction of these cells persists in the adult
nervous system as adult progenitor cells, while the majority
will progress into the premyelinating (or immature) oligo-
dendrocyte stage to eventually reach the mature myelinating
stage (oligodendrocyte development reviewed in [11, 55–
57]). Again as with Schwann cells, the differentiation
process of oligodendrocytes is controlled by a complex
network of transcription factors, which differs slightly
depending on the origin of the oligodendrocyte progenitor
pool [12]. Among these factors, Sox9 and Olig2 are early
essential transcription factors that are necessary for the
specification step into the oligodendrocyte lineage [58–61].
Further differentiation also necessitates Olig2, which
induces expression of Sox10, Nkx2.2, and platelet-derived
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growth factor receptor (PDGFR)-alpha [62–65]. Sox9 also
remains expressed and appears to have functions similar to
those of Sox10 on the activation of PDGFR-alpha expression
[66]. As for terminal differentiation, Olig1, Olig2, Sox10,
and the recently identified myelin gene regulatory factor play
major roles in the activation of myelin protein expression
[61, 65, 67–69]. In order to fine-tune this transcriptional
network, inhibitors of differentiation such as Id2 and Id4,
Sox5, Sox6, and Hes5 prevent precocious differentiation
[70–75].
Adding to this already complex network and to a large
degree, overlaying it as sort of master regulators, several
members of the HDAC family have been identified as
central regulators of the differentiation process. Studies
addressing the functions of HDACs in oligodendrocyte
differentiation started with the use of the broad HDAC
inhibitors trichostatin A (TSA) [76] and valproic acid
(VPA) [77]. These inhibitors have a large spectrum of
activity and can target virtually all classical HDACs,
although VPA is considered more specific towards class I
HDACs. Using these pharmacological approaches, Marin-
Husstege et al. [78] showed that HDAC activity is
necessary for the differentiation of OPCs in cell cultures.
Later, the same group confirmed the initial findings in vivo
by showing that HDAC activity is critical for the induction
of myelination in the rat corpus callosum. They hypothe-
sized that HDACs promote the myelination process in
oligodendrocytes by repressing the transcription of inhib-
itors of myelination [79]. Once the myelination process has
started in oligodendrocytes, HDAC activity is no longer
required. The authors correlated these observations with an
increase in the repressive histone mark H3K9me3 and with
heterochromatin protein 1 (HP1)-alpha expression at later
stages of postnatal development. Of note, acetylation and
deacetylation of histones are dynamic and reversible
modifications, whereas H3K9me3 and HP1-alpha binding
occurring after histone deacetylation are more stable marks
associated with heterochromatin.
Other studies using TSA demonstrated that HDAC
inhibition in neural stem cells favors the neuronal fate,
while inhibiting differentiation into OPCs. Furthermore,
TSA is able to reprogram OPCs into neural stem-like cells
capable of neurogenesis [80]. This plasticity induced by
HDAC inhibition involves re-expression of the stem cell
marker Sox2 by reactivation of the Sox2 promoter through
chromatin decompaction. In addition, HDAC inhibition by
TSA correlated with the reactivation of a dozen other genes
that mark the stem cell state, and with silencing of
oligodendrocyte lineage-specific genes [80]. BMP signaling
is also capable of reprogramming OPCs into neural stem-
like cells [81]. Since HDACs have been shown to inhibit
BMP signaling in several different systems [82, 83], it is
possible that HDACs favor differentiation into OPCs by
inhibiting BMP signaling. However, Lyssiotis et al. [80]
showed that gene expression induced by BMP2 in OPCs
does not completely overlap with the effect of TSA
treatment. Furthermore, TSA induces OPC reprogramming
even when BMP signaling is shut off. This indicates that
HDACs promote differentiation into OPCs in complex
ways with other contributions unrelated to BMP signaling.
Humphrey et al. [84] reported that overexpression in
neural stem cells of HDAC1, HDAC2, or HDAC3 mutants,
where enzymatic activity is strongly reduced or lost, results
in increased oligodendrocyte differentiation. The reasons
for these surprising effects are not clear. Finally, Swiss et al.
[85] established a list of “TSA-sensitive” genes during the
differentiation process of OPCs into mature oligodendro-
cytes. Among these genes, the authors identified Id2, Egr1,
and Sox11 as early targets of HDACs, regulated immediately
after induction of differentiation. Indeed, these three proteins
prevent oligodendrocyte differentiation and need to be
silenced for induction of the differentiation process [70, 85].
Later markers of oligodendrocyte differentiation such as
myelin genes were not found in this study to be regulated by
histone acetylation and deacetylation [85].
In summary, the use of pharmacological HDAC inhib-
itors provided a proof of concept that histone deacetylation
is crucial for oligodendrocyte differentiation. The next
challenge was, and still partially remains, the identification
of potential specific functions of individual members of the
HDAC family. HDACs were primarily considered as
general histone deacetylases. Although compensation may
occur between closely related HDACs, an increasing
number of studies are identifying specific/primary functions
of single HDACs. The first targeted study was carried out
in zebrafish where zHDAC1 was knocked out [86] (Note
that the zebrafish harbors only one HDAC1/HDAC2-like
gene called here zHDAC1). The authors show that
zHDAC1 is necessary for specification of OPCs.
zHDAC1-null neural stem cells continue to express Sox2
and fail to express Olig2 required for specification into the
oligodendrocyte lineage. Sonic hedgehog (Shh) is normally
expressed in zHDAC1 mutant hindbrain; however, the
absence of zHDAC1 renders Shh signaling inefficient in
inducing Olig2 expression.
OPCs can be reprogrammed in vitro into neural stem-
like cells [80, 81]. The RE1-silencing transcription factor
(REST) recruits HDAC1 and HDAC2 to stimulate OPC
differentiation and inhibits reprogramming into neural
stem-like cells [87]. The REST/HDAC complex represses
several neuronal genes and thereby favors glial cell
differentiation. Consistent with this, OPCs expressing a
dominant-negative REST are not able to differentiate into
mature oligodendrocytes and instead adopt a neuronal
phenotype [87]. These findings indicate that the REST/
HDACs complex is required for OPC differentiation.
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Oligodendrocyte differentiation is inhibited by Wnt/
ABC signaling [88–90]. Ye et al. [91] ablated both Hdac1
and Hdac2 simultaneously in the oligodendrocyte lineage
by crossing mice expressing the Cre recombinase under
control of the Olig1 promoter with mice carrying floxed
Hdac1 and floxed Hdac2 genes. In double mutant mice, the
formation and differentiation of OPCs were severely
impaired, and the ABC levels significantly increased. The
authors found that TCF4 (also called TCF7L2), a member
of the LEF/TCF family of proteins interacting with ABC, is
a transcriptional activator of the inhibitors of differentiation
Id2 and Id4 in OPCs. When HDAC1 and HDAC2 are
absent, Id2 and Id4 are upregulated, while markers of
oligodendrocyte differentiation (MBP (myelin basic pro-
tein) and CNPase (cyclic nucleotide phosphodiesterase)) are
reduced. Consistent with previous findings [92], HDAC1
and HDAC2 compete with ABC to interact with TCF4, and
TCF4/HDACs is a repressor complex necessary for oligoden-
drocyte differentiation. These findings suggest that HDAC1
and HDAC2 promote oligodendrocyte differentiation by
disrupting the interaction of ABC with TCF4 and switching
the role of TCF4 from an activator to a repressor of Id gene
expression.
Oligodendrocyte differentiation is also inhibited by
Notch signaling, which induces expression of the inhibitor
of differentiation Hes5 [93–95]. HDAC1 has been shown to
repress Notch signaling in a complex with SMRT [96, 97].
Thus, in addition to Wnt signaling, HDAC1 and HDAC2
may also negatively regulate Notch signaling to favor
oligodendrocyte development. However, Ye at al. did not
detect increased levels of Hes5 in double HDAC mutant
OPCs, rendering this possibility unlikely [91].
Mouse genetic approaches have identified Ying Yang 1
(YY1) as an essential transcription factor for OPC
differentiation and maturation in conjunction with HDAC1
[98]. Depletion of YY1 in the oligodendrocyte lineage,
using mice expressing the Cre recombinase under control of
the Cnp promoter and mice carrying a floxed Yy1 gene,
resulted in severe CNS hypomyelination. On the molecular
level, YY1 recruits HDAC1 to repress the promoters of the
inhibitors of myelination Id4 and TCF4 just after exit of
OPCs from the cell cycle. Taken together, the data indicate
that the YY1/HDAC1 complex is required in OPCs for
progression of the differentiation process. As a side note,
ablation of YY1 in the Schwann cell lineage resulted also in
severe hypomyelination in the PNS [99]. However, this
phenotype appears not to depend on HDAC functions. In
Schwann cells, YY1 is a transcriptional activator of
peripheral myelination that links neuregulin signaling with
Krox20 expression. In the CNS, the same research group
used the cuprizone-mediated demyelination–remyelination
model to show that OPCs in young mice remyelinate axons
more efficiently than OPCs in old mice [100]. Remyelination
was accompanied by downregulation of the early progenitor
markers Sox2 and Hes5 in young mice, whereas these two
markers remained highly expressed in OPCs from old mice.
The authors show that HDAC1 and HDAC2 are recruited to
the promoters of Sox2 and Hes5 in cultured OPCs upon
induction of differentiation and that this recruitment is more
efficient in young mouse OPCs compared to old mouse
OPCs. Furthermore, silencing of HDAC1 or HDAC2
resulted in the upregulation of Sox2 and prevented the
expression of differentiation markers. These findings suggest
that HDAC1 and HDAC2 promote OPC differentiation during
remyelination by downregulating Sox2 and Hes5. This
mechanism is age-dependent and may explain why remyeli-
nation becomes less efficient with age. Further understanding
of how HDAC1 and HDAC2 are recruited to the promoters of
Sox2 and Hes5 is necessary to attempt improving this
recruitment for the enhancement of remyelination during
aging. In addition, recently developed transgenic techniques
that allow spatially and temporally regulated gene alterations
of OPCs in development and regeneration are expected to be
highly beneficial in advancing our knowledge [101–103].
In a different study, Wei et al. reported that Nkx2.2
recruits an HDAC1/mSin3a complex to repress the MBP
promoter in immature oligodendrocytes [104]. In addition,
Ji et al. found that Nkx2.2 binds to and represses the
promoter of the class III HDAC Sirt2 in CG4 cells, an
oligodendroglial precursor cell line, and that Sirt2 promoted
the differentiation of CG4 cells [105]. These results may
appear contradictory to the described functions of HDAC1
in promoting oligodendrocyte differentiation. However, it is
also conceivable that tightly regulated repression of
precocious differentiation may be a prerequisite to adequate
oligodendrocyte lineage progression.
In contrast to HDAC1, HDAC11 (the only mammalian
class IV HDAC) can activate the myelin genes MBP and
proteolipid protein (PLP). HDAC11 is recruited at the last step
of oligodendrocyte differentiation to the promoters of these
genes to activate their transcription by histone deacetylation
[106]. Although conducted in vitro, using the oligodendro-
cyte cell line OL-1 and primary oligodendrocyte cultures,
and not yet confirmed in vivo, this study supports an
important function of HDAC11 in oligodendrocyte terminal
differentiation and myelination. This putative function of
HDAC11 is in accordance with its expression pattern in the
mouse brain, showing strong expression in oligodendrocytes
that increases during postnatal development [107].
HDAC6, a class II HDAC, is known to deacetylate
alpha-tubulin, thereby destabilizing microtubules and regu-
lating cytoskeletal dynamics [108]. Although HDAC6
expression by oligodendrocytes has not yet been clearly
demonstrated in vivo [109], it is tantalizing that HDAC6-
mediated microtubule destabilization is inhibited by TPPP/
p25 which binds to HDAC6 and stabilizes microtubules by
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preventing their depolymerization [110]. TPPP/p25 plays an
important role in oligodendrocyte differentiation [111] and
may mediate this effect by regulating HDAC6 and
microtubule organization. Similar to HDAC6, Sirt2 is also
an alpha-tubulin deacetylase [112]. In oligodendrocytes,
Sirt2 is targeted to the myelin sheath in a PLP/DM20-
dependent fashion and has also been found in paranodes
[54], where its presence coincides with that of stathmin-1 at
the start of myelin formation [113]. Sirt2 and stathmin-1 are
both microtubule-destabilizing proteins. Their simultaneous
presence during myelin formation suggests the existence of
a microtubule regulatory network, which is likely to control
process extension and membrane remodeling. Consistent
with this, Ji et al. [105] showed that Sirt2 overexpression
increases MBP expression and process extension in CG4
cells.
Conclusion
Among the transcription factors that control the differentiation
and myelination processes, some are common and have
similar functions in Schwann cell and oligodendrocyte
development, but many of them are different or are differen-
tially involved in both cell types. Consistent with this notion,
the HDACs regulating differentiation and myelination act
through distinct mechanisms in Schwann cells and oligoden-
drocytes. However, despite using largely different mecha-
nisms of action, HDACs involved in the development of
myelinating cells seem remarkably determined to guide both
cell types through differentiation and myelination. Under-
standing the precise molecular and cellular functions of the
different forms of HDACs, together with the identification of
their individual targets, will help in designing new therapeutic
strategies for repair of the PNS and CNS in neurodegenerative
diseases and after injury. One of the main challenges will be to
elucidate the complex interplay between the different mem-
bers of the HDAC family, their potential compensatory
mechanisms, and very importantly to determine how their
expression and activities are regulated. In this regard, while a
growing number of HDAC inhibitors are being developed,
with increasing selectivity towards individual HDACs [114],
the availability of HDAC activators is nearly inexistent.
Given the strong commitment of HDACs to induce
differentiation of myelinating cells, the possibility to increase
their expression and activity is a promising strategy to be
considered towards improvement of remyelination in dis-
eases and after injuries of the nervous system.
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